| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/17/2011 | US20110064758 Infectious clones of torque teno virus |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064754 Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines |
| 03/17/2011 | US20110064753 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 03/17/2011 | US20110064752 Extracellular targeted drug conjugates |
| 03/17/2011 | US20110064751 Targeted immunoconjugates |
| 03/17/2011 | US20110064745 Therapeutic Antibodies, Antibody Fragments And Antibody Conjugates |
| 03/17/2011 | US20110064743 Human anti-cancer antibodies |
| 03/17/2011 | US20110064741 Stable amyloid beta monomers and oligomers |
| 03/17/2011 | US20110064740 Antigen binding proteins |
| 03/17/2011 | US20110064739 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
| 03/17/2011 | US20110064737 ErbB ANTAGONISTS FOR PAIN THERAPY |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064733 Ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 03/17/2011 | US20110064729 Administration of agents for the treatment of inflammation |
| 03/17/2011 | US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof |
| 03/17/2011 | US20110064727 Immunoglobulin Variants Outside the Fc Region |
| 03/17/2011 | US20110064726 ANTI IgE ANTIBODIES |
| 03/17/2011 | US20110064725 High affinity, anti-human ige antibodies |
| 03/17/2011 | US20110064722 Modulators of alpha-synuclein toxicity |
| 03/17/2011 | US20110064689 In situ immunization |
| 03/17/2011 | US20110064666 Compound |
| 03/17/2011 | US20110064654 Prostate cancer diagnosis and treatment |
| 03/17/2011 | US20110064653 Class I Anti-CEA Antibodies and Uses Thereof |
| 03/17/2011 | CA2809819A1 Extracellular targeted drug conjugates |
| 03/17/2011 | CA2773614A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | CA2773579A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| 03/17/2011 | CA2773564A1 Libraries of genetic packages comprising novel hc cdr3 designs |
| 03/17/2011 | CA2773541A1 High affinity human antibodies to human protease-activated receptor-2 |
| 03/17/2011 | CA2773218A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 03/17/2011 | CA2772590A1 Antibodies against glucagon receptor and their use |
| 03/17/2011 | CA2770235A1 Method to improve virus removal in protein purification |
| 03/16/2011 | EP2295580A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 03/16/2011 | EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof |
| 03/16/2011 | EP2295575A2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/16/2011 | EP2295544A2 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| 03/16/2011 | EP2295469A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 03/16/2011 | EP2295468A1 Anti-CD20 antibodies and fusion proteins thereof and methods of use |
| 03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 03/16/2011 | EP2295466A2 Antibodies to myostatin |
| 03/16/2011 | EP2295465A2 Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295455A1 Cytokine receptor |
| 03/16/2011 | EP2295454A1 SLO2, a novel potassium channel protein from human brain |
| 03/16/2011 | EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/16/2011 | EP2295082A1 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295080A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 03/16/2011 | EP2295079A2 Method for treating inflammation |
| 03/16/2011 | EP2295078A2 Method for treating inflammation |
| 03/16/2011 | EP2295073A1 Antibody against CD22 for the treatment of tumour of hematopoietic origin |
| 03/16/2011 | EP2295071A1 Low dose methods for treating disorders in which TNF-alpha activity is detrimental |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294197A2 Variant hhip1 protein and methods and uses thereof |
| 03/16/2011 | EP2294184A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 03/16/2011 | EP2294179A2 Induction of flocculation in photosynthetic organisms |
| 03/16/2011 | EP2294178A2 Methods, compositions and apparatus for facilitating regeneration |
| 03/16/2011 | EP2294089A2 Anti-fn14 antibodies and uses thereof |
| 03/16/2011 | EP2294088A1 Antibodies against extracellular domains 2 and 3 or her2 |
| 03/16/2011 | EP2294087A1 Anti-hepcidin antibodies and methods of use |
| 03/16/2011 | EP2294086A2 Anti-inflammatory agents |
| 03/16/2011 | EP2294085A1 Antibodies against neisserial factor h binding protein |
| 03/16/2011 | EP2294084A1 Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 03/16/2011 | EP2293819A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 03/16/2011 | EP2293816A1 Methods for the treatment of rheumatoid arthritis |
| 03/16/2011 | EP2293667A2 Interleukin 10 receptor (il-10r) antibodies and methods of use |
| 03/16/2011 | EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 03/16/2011 | EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 03/16/2011 | EP1745297B1 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 03/16/2011 | EP1564285B1 Method of obtaining a recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media |
| 03/16/2011 | EP1551876B1 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof |
| 03/16/2011 | EP1436320B1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | EP1383785B1 Recombinant tumor specific antibody and use thereof |
| 03/16/2011 | CN101986784A Engineered anti-TSLPR antibodies |
| 03/16/2011 | CN101986783A Anti-MDL-1 antibodies |
| 03/16/2011 | CN101985476A Preparation, identification and application of antihuman NKp30 monoclonal antibody |
| 03/16/2011 | CN101985475A Novel polyclonal antibody of secretive peptide INM02 and preparation method and use thereof |
| 03/16/2011 | CN101985474A Monoclonal antibody TBCA6 resistant to mycobacterium tuberculosis CFP-10 and application |
| 03/16/2011 | CN101985473A Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application thereof |
| 03/16/2011 | CN101985472A Monoclonal antibody TBCD6 resistant to mycobacterium tuberculosis CFP-10 and application |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985468A SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 03/16/2011 | CN101985036A Amyloid- beta (1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 03/16/2011 | CN101362796B B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 03/15/2011 | US7906640 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906627 Chimeric human sweet-umami and umami-sweet taste receptors |
| 03/15/2011 | US7906626 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 03/15/2011 | US7906625 Humanized anti-amyloid antibody |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906484 Complex for transferring an anionic substance into a cell |
| 03/15/2011 | US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP) |
| 03/15/2011 | US7906329 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 03/15/2011 | US7906327 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 03/15/2011 | US7906302 Methods of preventing or treating contact dermatitis |